In silico predictions of drug solubility and permeability:: Two rate-limiting barriers to oral drug absorption

被引:47
|
作者
Bergström, CAS [1 ]
机构
[1] Uppsala Univ, BMC, Dept Pharm, Ctr Pharmaceut Informat, SE-75123 Uppsala, Sweden
关键词
D O I
10.1111/j.1742-7843.2005.pto960303.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aqueous drug solubility and intestinal drug permeability are two of the most important factors influencing drug absorption. If the developability of a drug is to be included in the lead optimization, new experimental and computational models of solubility and permeability are needed. These models must have the capacity to handle a large amount of data. Nowadays, epithelial cell culture models such as Caco-2 are routinely used to assess intestinal drug permeability and transport in drug discovery settings. The permeability values obtained from the Caco-2 cell monolayers have been traditionally used to devise in silico models for the prediction of drug absorption. In this paper, the use of molecular surface areas as descriptors of permeability and solubility will be reviewed. Moreover, a virtual filter for the prediction of oral drug developability based on the successful combination of in vitro and in silico models of drug permeability and aqueous drug solubility will be discussed.
引用
收藏
页码:156 / 161
页数:6
相关论文
共 50 条
  • [1] RATE-LIMITING BARRIERS TO INTESTINAL DRUG ABSORPTION - A REVIEW
    HAYTON, WL
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (04): : 331 - 334
  • [2] RATE-LIMITING BARRIERS IN INTESTINAL-ABSORPTION
    GIBALDI, M
    GRUNDHOFER, B
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1972, 141 (02): : 564 - +
  • [3] RATE-LIMITING STEPS IN DRUG METABOLISM
    SCHENKMAN, JB
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1971, 3 (04) : 306 - +
  • [4] Pediatric Drug Formulations: A Rate-Limiting Step
    Milap C. Nahata
    [J]. Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 393 - 396
  • [5] Pediatric drug formulations: A rate-limiting step
    Nahata, MC
    [J]. DRUG INFORMATION JOURNAL, 1999, 33 (02): : 393 - 396
  • [6] RATE-LIMITING STEP IN RECONSTITUTED MICROSOMAL DRUG HYDROXYLASE SYSTEM
    IMAI, Y
    SATO, R
    IYANAGI, T
    [J]. JOURNAL OF BIOCHEMISTRY, 1977, 82 (05): : 1237 - 1246
  • [7] Intestinal transport and metabolism of analgesic dipeptide, kyotorphin: Rate-limiting factor in intestinal absorption of peptide as drug
    Mizuma, T
    Koyanagi, A
    Awazu, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1997, 1335 (1-2): : 111 - 119
  • [9] In Silico Predictions of ADME-Tox Properties: Drug Absorption
    Geerts, Tessy
    Heyden, Yvan Vander
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2011, 14 (05) : 339 - 361
  • [10] In silico and permeability models to evaluate oral drug absorption and their application to novel anticancer agents.
    Wood, Nadya L.
    Box, Gary
    Eccles, Suzanne
    Henley, Alan
    Bavetsias, Vassilios
    Jackman, Ann L.
    Workman, Paul
    Raynaud, Florence
    [J]. CANCER RESEARCH, 2006, 66 (08)